Jupiter Life Line Hospitals (NSE:JLHL) Quality Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:JLHL Jupiter Life Line Hospitals Ltd NSE:JLHL
94 GF Score
Price ₹275.55
GF Value ₹355.71
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Jupiter Life Line Hospitals Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Jupiter Life Line Hospitals Quality Rank Related Terms

NSE:JLHL
94GF Score
Jupiter Life Line Hospitals Ltd NSE:JLHL
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Jupiter Life Line Hospitals (NSE:JLHL) Overvalued in 2026?

Based on GuruFocus' analysis, Jupiter Life Line Hospitals stock appears to be undervalued. The current stock price of ₹275.55 is trading 22.5% below its estimated GF Value™ of ₹355.71. GuruFocus considers Jupiter Life Line Hospitals to be Modestly Undervalued.

Key valuation signals for NSE:JLHL:

  • Quality Rank:
  • GF Value™: ₹355.71 vs. price of ₹275.55 (22.5% below fair value)
  • GF Score™: 94/100 with 1 warning sign

No single metric tells the full story. See the NSE:JLHL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jupiter Life Line Hospitals Business Description

Other Exchanges 543980:India
Address Eastern Express Highway, Service Road, Next To Viviana Mall, Thane west, Thane, MH, IND, 400601
Jupiter Life Line Hospitals Ltd is a key multi-specialty tertiary and quaternary healthcare provider. The Company operates in one business and geographical segment that is Medical and Healthcare Services in India. The Hospital revenue comprises of fees charged for inpatient and outpatient hospital services and other hospital services. Services include charges for accommodation, operation theatre, medical professional services, equipment, radiology, laboratory, and pharmaceutical goods used for treating patients.
94GF Score

Get the complete analysis for NSE:JLHL

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹275.55
Price
₹355.71
GF Value